美股异动｜赛默飞世尔涨超2.2%，与OpenAI合作提高药物开发效率

Core Viewpoint - Thermo Fisher Scientific (TMO.US) has seen a stock increase of over 2.2%, reaching $539.55, due to its collaboration with OpenAI aimed at enhancing the speed and success rate of drug development [1] Company Summary - Thermo Fisher Scientific is integrating OpenAI APIs into various areas including product development, service delivery, and customer engagement to improve efficiency in drug development [1]